Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 2Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Radiation Injuries 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Papillomavirus Infections 1Lymphoma, Non-Hodgkin 1Lymphoma 1Hodgkin Disease 1

Interventions

Cyclophosphamide 25fludarabine phosphate 22Peripheral Blood Stem Cell Transplantation 22Whole-Body Irradiation 15Etoposide 13Cyclosporine 13Mycophenolic Acid 12Busulfan 12Tacrolimus 11Filgrastim 11Antilymphocyte Serum 11Methotrexate 9Prednisone 8Dexamethasone 8nelarabine 7Radiotherapy 7Doxorubicin 7Vincristine 6Methylprednisolone 6Calcium Dobesilate 6Vorinostat 5Paclitaxel 5Lenalidomide 5Everolimus 5Carboplatin 5Bortezomib 5merphos 4aldesleukin 4Therapeutics 4Rituximab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Pentetic Acid × Clear all
NCT00019227 2013-06-20

Monoclonal Antibody Therapy in Treating Patients With Leukemia

National Cancer Institute (NCI)

Phase 1/2 Completed
LymphoidOther hematologic neoplasm

Lymphoma, Radiation Injuries, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡